Skip to main content
SpringerLink
Log in

Onkologie und Versorgung in Fach- und Publikumsmedien

Doch Krebsrisiko durch Brustimplantate? Kann man bei Lungenkrebs die Chemotherapie inhalieren? Polypenentfernung mit Wasserstrahlchirurgie? Desensibilisierungsbehandlung nach (Brust-)Krebs ohne Risiko möglich? Wechselwirkungen von Heilpilzen mit Zytostatika?

  • Was Patienten fragen
  • Published:
Der Onkologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Institut National du Cancer (INCa) (2015) Avis d’experts sur les lymphomes anaplasiques à grandes cellules associés à un implant mammaire – avis d‘experts http://www.e-cancer.fr/toutes-les-actualites/84-linstitut-national-du-cancer/9373-avis-dexperts-sur-les-lymphomes-anaplasiques-a-grandes-cellules-associes-a-un-implant-mammaire

  2. Brody GS et al (2015) Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 cases. Plast Reconstr Surg 135(3):695–705

    Article  CAS  PubMed  Google Scholar 

  3. FDA (2011) Reports of Anaplastic Large Cell Lymphoma (ALCL) in Women with Breast Implants: FDA Safety Communication http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm240000.htm

  4. BfArM (2011/2015) Möglicher Zusammenhang zwischen Brustimplantaten und der Entstehung eines anaplastischen großzelligen Lymphoms (ALCL) http://www.bfarm.de/SharedDocs/Risikoinformationen/Medizinprodukte/DE/Brustimplantate_ALCL_FDA.html

  5. Miranda RN et al (2014) Breast implant-associated anaplastic large-cell lymphoma: Long-term follow-up of 60 patients. J Clin Oncol 32:114–120

    Article  PubMed Central  PubMed  Google Scholar 

  6. Ye X et al (2014) Anaplastic large cell lymphoma (alcl) and breast implants: Breaking down the evidence. Mutat Res Rev Mutat Res 762:123–132

    Article  CAS  PubMed  Google Scholar 

  7. Kim B et al. (2015). Breast Implant–associated Anaplastic Large Cell Lymphoma: Updated Results from a Structured Expert Consultation Process. Plast Reconstr Surg Glob Open 3(1):e296

    Article  PubMed Central  PubMed  Google Scholar 

  8. Zarogoulidis P et al. (2012) Inhaled chemotherapy in lung cancer: future concept of nanomedicine. Int J Nanomedicine 7:1551–1572

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Belle S et al. (2012 Feb; epub 2011 Oct 13) Selective tissue elevation by pressure for endoscopic mucosal resection of colorectal adenoma: first clinical trial. Surg Endosc 26(2):343–349

    Article  CAS  PubMed  Google Scholar 

  10. Takeuchi Y et al. (2010 Feb; epub 2009 Sep 22) Efficacy of an endo-knife with a water-jet function (Flushknife) for endoscopic submucosal; eb dissection of superficial colorectal neoplasms. Am J Gastroenterol 105(2):314–322

    Article  PubMed  Google Scholar 

  11. Toyanaga T et al. (2008) The results and limitations of endoscopic submucosal dissection for colorectal tumors. Acta Chir Iugosl 55(3):17–23

    Article  CAS  PubMed  Google Scholar 

  12. Ziachehabi A (2014) Endoskopische Submukosadissektion. Wien Klin Mag 17:8–11

    Article  Google Scholar 

  13. Akdis M, Akdis CA (2014) Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. J Allergy Clin Immunol 133(3):621–631

    Article  CAS  PubMed  Google Scholar 

  14. Wöhrl S et al. (2011) Malignancy and Specific Allergen Immunotherapy: The Results of a Case Series. Int Arch Allergy Immunol 156(3):313–319

    Article  PubMed  Google Scholar 

  15. Bozek A et al. (2014) The safety of specific immunotherapy for patients allergic to house-dust mites and pollen in relation to the development of neoplasia and autoimmune disease: a long-term, observational case-control study. Int Arch Allergy Immunol 163(4):307–312

    Article  CAS  PubMed  Google Scholar 

  16. S2k-Leitlinie zur (allergen-)spezifischen Immuntherapie bei IgE-vermittelten allergischen Erkrankungen (2014) Allergo J Int 23: 282 http://www.awmf.org/uploads/tx_szleitlinien/061-004l_S2k_SIT_2014-12.pdf

  17. Büssing A, Hübner J (2009) Asiatische Heilpilze. Der Onkologe 15(5): 519–525

    Article  Google Scholar 

  18. Engdal S, Nilsen OG (2009) In vitro inhibition of CYP3A4 by herbal remedies frequently used by cancer patients. Phytother Res. 2009 Jul;23(7): 906–912

  19. Wang X et al. (2007) Effects of Ganoderma lucidum polysaccharide on CYP2E1, CYP1A2 and CYP3A activities in BCG-immune hepatic injury in rats. Biol Pharm Bull 30(9):1702–1706

    Article  CAS  PubMed  Google Scholar 

  20. Yeung JH, Or PM (2012) Polysaccharide peptides from Coriolus versicolor competitively inhibit model cytochrome P450 enzyme probe substrates metabolism in human liver microsomes. Phytomedicine 19(5):457–463

    Article  CAS  PubMed  Google Scholar 

  21. Stellungnahme der Gemeinsamen Expertenkommission des BVL / BfArM „Einstufung bestimmter Vitalpilzprodukte (Nr. 01/2014)“

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. A. Gaisser gibt an, dass kein Interessenkonflikt besteht.

Der Beitrag enthält keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

  1. Krebsinformationsdienst KID, Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280, 69120, Heidelberg, Deutschland

    A. Gaisser

Authors
  1. A. Gaisser
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Gaisser.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gaisser, A. Onkologie und Versorgung in Fach- und Publikumsmedien. Onkologe 21, 734–738 (2015). https://doi.org/10.1007/s00761-015-3002-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-015-3002-5

Search

Navigation